TG Therapeutics Inc vs Williams-Sonoma, Inc. — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while Williams-Sonoma, Inc. trades at $223.2 (market cap $26.30B). The key difference: Williams-Sonoma, Inc. is far larger — about 3.2× TG Therapeutics Inc's market cap, and Williams-Sonoma, Inc. pays a 1.36% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| TGTX | WSM | |
|---|---|---|
Market Cap | $8.26B | $26.30B |
Sector | Health | Consumer Cyclical |
52-Week High | $59.06 | $240.06 |
52-Week Low | $26.39 | $168.64 |
Enterprise Value | $8.50B | $27.14B |
Dividend Yield | — | 1.36% |
Trailing returns across standard periods
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Read more on WSM →